Lilly rides Mounjaro, Zepbound to better
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit.
The drugmaker also hiked its sales and earnings forecast for 2024 beyond Wall Street’s expectations even as it hustles to boost manufacturing and catch up to surging demand for the drugs.
Lilly said it was still dealing with supply issues that also hampered the company in the fourth quarter. Company officials expect that to persist through this year, but they emphasized Tuesday that help was on the way.
They expect significant manufacturing increases to occur, starting in the back half of the year.
CEO David Ricks told analysts Tuesday that Lilly was undergoing “the most ambitious expansion plan in our company’s history.”
Indianapolis-based Eli Lilly and Co. recorded $517 million in sales from Zepbound, which received approval from U.S. regulators last November. Total Mounjaro sales more than tripled to $1.81 billion from $568 million in last year’s quarter.
Related articles
ACL injuries are more common in women soccer players than men. We may learn why
An English study into the causes of knee injuries to women soccer players was launched on Tuesday.‘P2024-05-01Chinese home appliance firms expand global market with great vigor
By upgrading their products and increasing outbound investments, Chinese home appliance companies ha2024-05-01Primary, secondary schools reopen in Ireland under phased plan
Students enter a school in Dublin, Ireland, on March 1, 2021. Primary and secondary schools in Irela2024-05-01World should act as one when it needs China to play a role in creating economic growth
Affected by the COVID-19 pandemic, it’s not easy for the global economy to recover and improve withi2024-05-01New Jersey seeks fourth round of offshore wind farm proposals as foes push back
LONG BEACH TOWNSHIP, N.J. (AP) — New Jersey is seeking a new round of proposals to build wind energy2024-05-01China hands over donated COVID
A Palestinian man prepares to unload the Sinopharm COVID-19 vaccines in the West Bank city of Ramall2024-05-01
atest comment